Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health

Can some types of fat protect us from brain disease?

by University of California at Berkeley
September 8, 2016
in Mental Health
Photo credit: Hyun-eui Kim

Photo credit: Hyun-eui Kim

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

An intriguing finding in nematode worms suggests that having a little bit of extra fat may help reduce the risk of developing some neurodegenerative diseases, such as Huntington’s, Parkinson’s and Alzheimer’s diseases.

What these illnesses have in common is that they’re caused by abnormal proteins that accumulate in or between brain cells to form plaques, producing damage that causes mental decline and early death.

Huntington’s disease, for example, is caused by aggregating proteins inside brain neurons that ultimately lead to motor dysfunction, personality changes, depression and dementia, usually progressing rapidly after onset in people’s 40s.

These protein aggregates – called Huntington’s aggregates – have been linked to problems with the repair system that nerve cells rely on to fix proteins that fold incorrectly: the cell’s so-called protein folding response. Misfolded proteins can make other proteins fold incorrectly, creating a chain reaction of misfolded proteins that form clumps that the cell can’t deal with.

When University of California, Berkeley, researchers perturbed the powerhouses of the cell, the mitochondria, in a strain of the nematode C. elegans that mimics Huntington’s disease, they saw their worms grow fat. They traced the effect to increased production of a specific type of lipid that, surprisingly, prevented the formation of aggregate proteins. The fat, they found, was required to turn on genes that protected the animals and cells from Huntington’s disease, revealing a new pathway that could be harnessed to treat the disease.

The same proved true in human cell lines cultured in a dish.

“We found that the worms and human cells were almost completely protected from the Huntington’s aggregates when we turned on this response,” said Andrew Dillin, the Thomas and Stacey Siebel Distinguished Chair in Stem Cell Research in UC Berkeley’s Department of Molecular and Cell Biology and a Howard Hughes Medical Institute investigator.

They subsequently treated worms and human cells with Huntington’s disease with drugs that prevented the cell from sweeping up and storing the lipid, called ceramide, and saw the same protective effect.

“If we could manipulate this lipid pathway, we could go after Huntington’s disease, because in our studies the drugs were really beneficial,” he said. “This is poised to take to the next level.”

Dillin has already begun experiments in mice with Huntington’s disease to see if the drugs result in a better outcome. He will publish his latest findings online Sept. 8 in the journal Cell.

How Huntington’s disease causes wasting

In an accompanying paper in the same issue of Cell, Dillin also reports that stressing neurons in the brain makes them release a hormone, serotonin, that sends alert messages throughout the body that the brain cells are under attack, setting off a similar stress response in cells far from the brain. In diseases like Huntington’s, mental decline is also associated with peripheral metabolic defects and muscle decline.

“The serotonin release dramatically changes the metabolic output of peripheral cells and the sources they use for fuel, so we think it is instituting a large-scale metabolic rewiring, maybe to protect the neurons in the brain,” he said. “If you begin to shut down the periphery and stop using the limited resources it utilizes, then more of those resources can be shifted to brain metabolic activity. This might be a very clever way to try to save the brain by having the body waste away.”

While Dillin discovered the ability of mitochondria to communicate between different cells and tissues several years ago, the new study pinpoints serotonin as a primary driver of this metabolic response, he said.

Dillin noted that drugs that lower levels of serotonin have long been used to treat depression and other psychiatric manifestations of neurodegenerative diseases, but the new findings suggest these medications may have more widespread use in age-related disease than was previously thought. These findings have broad implications not only for the potential treatment of neurodegenerative disorders, but for further understanding the impact of neurological disease on metabolism and stress responses throughout the body.

Mitochondria key to brain degeneration

Both discoveries came from studies of mitochondria, the powerhouses of the cell that burn nutrients for energy but also play a key role in signaling, cell death and growth. Over the past several years, increasing evidence has associated mitochondrial dysfunctions with aging and age-onset protein misfolding diseases such as Alzheimer’s, Parkinson’s and Huntington’s.

Dillin is particularly interested in Huntington’s disease, which is inherited and strikes people in their 40s and 50s, inevitably leading to a wasting death. The genetic cause is well-known – expansion of a part of a gene that produces a protein with too many added glutamine amino acids. How this glutamine-rich protein leads to symptoms is only graduatlly being revealed.

While investigating mitochondria in nematodes genetically engineered to have Huntington’s disease, Dillin and his colleagues discovered that the abnormal proteins actually aggregate on the mitochondria, and that this ramps up the protein folding response within the cell, flooding both the mitochrondria and the cell interior with nearly 100 types of so-called heat shock proteins to try to fix the misfolded proteins. The heat-shock proteins act as mitochondrial chaperones to assist in the import and folding of mitochondrial proteins synthesized outside of mitochondria.

The researchers were surprised to find that knockdown of one specific mitochondrial chaperone, mtHSP70, elicited a unique stress response mediated by fat accumulation, resulting in improved protein folding in the interior or cytosol of the cell. Drugs that activate this novel stress response pathway, which they call the mitochondrial-to-cytosolic stress response, protected both nematodes and cultured human cells with Huntington´s disease from protein-folding damage.

“Maybe there is a way to use one drug to alter the mitochondrial signal and another drug to alter the communciation signal from the brain,” he said. “You would never see these two effects if you were studying protein folding in a tissue culture dish, because you don’t have the whole organism, C. elegans, in which you can look at the signals being communicated.”

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

A surprising body part might provide key insights into schizophrenia risk
Addiction

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

July 11, 2025

After heroin exposure and abstinence, mice showed reduced prefrontal brain activity during social interaction but heightened responses to drug-related cues, suggesting heroin disrupts normal brain function in ways that may contribute to social withdrawal and relapse risk.

Read moreDetails
A surprising body part might provide key insights into schizophrenia risk
Alzheimer's Disease

New research identifies four distinct health pathways linked to Alzheimer’s disease

July 11, 2025

Researchers identified four common disease pathways—centered on mental health, brain disorders, cognitive decline, and vascular issues—that often precede Alzheimer’s, showing that the sequence of conditions may better predict risk than individual diagnoses alone.

Read moreDetails
A surprising body part might provide key insights into schizophrenia risk
Mental Health

A surprising body part might provide key insights into schizophrenia risk

July 11, 2025

A new study published in Nature Mental Health has found that people with a higher genetic risk for schizophrenia tend to have thinner retinas, even if they do not have the disorder. Using data from nearly 35,000 healthy individuals, the researchers showed that this association was especially pronounced in areas...

Read moreDetails
A common vegetable may counteract brain changes linked to obesity
Mental Health

A common vegetable may counteract brain changes linked to obesity

July 11, 2025

Could a humble vegetable protect the brain from the effects of early-life overfeeding? A new rat study finds that okra improves insulin sensitivity and reduces inflammation in key brain areas linked to appetite and obesity.

Read moreDetails
Dementia: Your lifetime risk may be far greater than previously thought
Dementia

Dementia: Your lifetime risk may be far greater than previously thought

July 10, 2025

A recent study shows a staggering 42% of Americans may develop dementia, with women and Black adults at even higher risk. Researchers say what's missing from prevention efforts is a focus on the pervasive role of chronic stress.

Read moreDetails
Is ChatGPT really more creative than humans? New research provides an intriguing test
ADHD

Scientists use deep learning to uncover hidden motor signs of neurodivergence

July 10, 2025

Diagnosing autism and attention-related conditions often takes months, if not years. But new research shows that analyzing how people move their hands during simple tasks, with the help of artificial intelligence, could offer a faster, objective path to early detection.

Read moreDetails
Adults with ADHD face significantly shorter life expectancy, study finds
Anxiety

Study finds “Anxious Mondays” linked to long-term stress and heart health risks in older adults

July 10, 2025

Researchers have discovered that anxiety felt on Mondays is associated with higher long-term cortisol levels in older adults, suggesting the start of the week may contribute to biological stress in ways that extend far beyond the office.

Read moreDetails
Loss of empathy in frontotemporal dementia traced to weakened brain signals
ADHD

Adults treated with psychostimulants for ADHD show increased brain surface complexity, study finds

July 10, 2025

Researchers have discovered that long-term psychostimulant use in adults with ADHD is associated with increased brain surface complexity, yet these anatomical differences appear unrelated to clinical outcomes, according to a study using high-resolution MRI data from UCLA.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

New research identifies four distinct health pathways linked to Alzheimer’s disease

A surprising body part might provide key insights into schizophrenia risk

Religious belief linked to lower anxiety and better sleep in Israeli Druze study

A common vegetable may counteract brain changes linked to obesity

Massive psychology study reveals disturbing truths about Machiavellian leaders

Dementia: Your lifetime risk may be far greater than previously thought

Psychopathic tendencies may be associated with specific hormonal patterns

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy